Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexium for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients
NCT05267613Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of esomeprazole in erosive esophagitis (EE), sponsored by AstraZeneca. Started Jul 2022; status: completed.
02
Drugs
esomeprazole
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT05267613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05267613.